Proteostasis
News & Events
     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

News items that are marked with ** are non-public articles that the publisher has secured with a digital rights system. Proteostasis has purchased viewing rights to these articles. In order to view the articles, you must download the .EXE file associated with the link on the article. After you download the file, you must then run it on your local computer and it will give you access to the article. The .EXE files are safe and virus free. If you have any questions, you may contact us at webadmin@proteostasis.com

News

Press Releases

10.20.2011 - Proteostasis Therapeutics Announces Appointment of Mark J. Enyedy as Chief Executive Officer

09.15.2011 - Proteostasis Therapeutics’ Scientific Advisory Board Chairman, F. Ulrich Hartl, M.D., D. Med, Receives Lasker Award for Basic Medical Research

05.25.2011 - Proteostasis Therapeutics & Elan Form Drug Discovery Initiative,
Strategic Relationship Combines Proteostasis’ Proprietary “Proteostasis Network” Platform With Elan’s Biology, Genetics And Neurology Disease Expertise

05.05.2011 - Harvard University’s Alfred Goldberg, Ph.D., Daniel Finley, Ph.D., and Randall King, M.D., Ph.D., Named Proteostasis Scientific Co-Founders

04.26.2011 - Proteostasis Therapeutics Licenses Novel Protein Clearance Targets, Compounds from Harvard University

11.16.2010 - Proteostasis Therapeutics Enters into Research Collaboration
with Harvard University - Laboratory of Dr. Laurie Glimcher


03.25.2010 - Proteostasis Therapeutics Announces Addition of Key Executive

01.07.2010 - Proteostasis Therapeutics Exclusively Licenses Discoveries Related to Unfolded Protein Response from Ron Laboratory at New York University

12.15.2009 - Proteostasis Scientific Founders Publish Paper in Cell Establishing Role of the Proteostasis Network in Alzheimer's Disease

12.06.2009 - Proteostasis Advisors Publish Research in Nature Chemical Biology Demonstrating Improved Lung Cell Function in Cystic Fibrosis

08.25.2008 - Proteostasis Therapeutics Secures a $45 Million Series A Financing to Develop Proteostasis Regulator™ Drugs

In The News

03.15.11 Genetic Engineering & Biotechnology News
“Arresting Disorderly Proteins for Disease Treatment” [Link to article]

03.10.11 SciBx
“Cancer Stress Tests” [Link to abstract]

** November 2010  Nature Reviews Drug Discovery
"Modifying Protein Misfolding" [Link to download article]

06.01.10  TheScientist
"The accumulation of misfolded protein marks the accrual of years as the body ages. Could heat shock proteins be used to reduce the effects of aging and diminish the risk of disease by untangling improperly folded proteins?" [Link to article]

05.03.10   Xconomy
"Proteostasis, with San Diego Roots and Boston Home, Seeks Edge in Alzheimer’s and Parkinson’s" [Link to article]

02.18.10   Xconomy
"Proteostasis, a Rich Boston Biotech with San Diego Ties, Grows to Pursue Diseases of Aging" [Link to article]

01.07.10   SciBX
"Reaching the Surface in CF" [Link to article]

12.11.09   BioWorld Today
"Plaques, Bad Cholesterol Get Partial Rehab in Alzheimer’s" [Link to article]

** December 2009  Nature Biotechnology
"Why protein homeostasis has investors excited" [Link to download article]

04.13.2009  Boston Globe
“Local companies delve deep into cell origami” [Link to article]

09.15.2008  Xconomy
“Proteostasis eyes technique to keep your proteins in balance” [Link to article]

08.24.2008  Boston Globe
“Cultivating the next Big Idea company” [Link to article]